8-K 1 a2025299z8-k.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 -------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 -------------- Date of Report (Date of earliest event reported): September 8, 2000 Vertex Pharmaceuticals Incorporated (Exact name of registrant as specified in its charter) Massachusetts 000-19319 04-3039129 ----------------------- -------------------- ------------------- (State or other (Commission (IRS Employer jurisdiction of File Number) Identification No.) incorporation)
130 WAVERLY STREET CAMBRIDGE, MA 02139 --------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (617) 577-6000 -------------------------------------------------------------------------------- Page 1 of 8 pages ITEM 5. OTHER EVENTS. On September 8, 2000, we publicly disseminated a press release announcing our intention to redeem our 5% Convertible Subordinated Notes due 2007. The information contained in the press release is incorporated herein by reference and filed as Exhibit 99.1 hereto. Also on September 8, 2000, we publicly disseminated a press release announcing a $200 million private offering of Convertible Subordinated Notes. The information contained in the press release is incorporated herein by reference and filed as Exhibit 99.2 hereto. ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. (c) Exhibits. 99.1 Press Release dated September 8, 2000, "Vertex Pharmaceuticals Announces its Intention to Redeem its 5% Convertible Subordinated Notes Due 2007." 99.2 Press Release dated September 8, 2000, "Vertex Pharmaceuticals Announces $200 Million Private Offering of Convertible Subordinated Notes." Page 2 of 8 pages SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VERTEX PHARMACEUTICALS INCORPORATED (Registrant) Date: September 8, 2000 By: /s/ Thomas G. Auchincloss, Jr. --------------------------------- Name: Thomas G. Auchincloss, Jr. Title: Vice President, Finance Page 3 of 8 pages EXHIBIT INDEX Exhibit Sequential Number Description Page Number ------- ----------- ----------- 99.1 Press Release dated September 5 8, 2000, "Vertex Pharmaceuticals Announces its Intention to Redeem its 5% Convertible Subordinated Notes Due 2007." 99.2 Press Release dated September 7 8, 2000, "Vertex Pharmaceuticals Announces $200 Million Private Offering of Convertible Subordinated Notes." Page 4 of 8 pages